secwatch / observer
8-K filed April 15, 2026, 7:59 PM ET ticker WVE CIK 0001631574
other material confidence high sentiment neutral materiality 0.55

Wave Life Sciences announces redomiciliation to Delaware, shares to exchange 1:1

Wave Life Sciences Ltd.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Wave Life Sciences Ltd. entered into Implementation Agreement with Wave Life Sciences, Inc. (Wave-Delaware) valued at Exchange all Wave-Singapore ordinary shares for Wave-Delaware common stock on a one-for-one basis; R (effective 2026-04-15).

Action
entry
Agreement
merger
Counterparty
Wave Life Sciences, Inc. (Wave-Delaware)
Value
Exchange all Wave-Singapore ordinary shares for Wave-Delaware common stock on a one-for-one basis; R
Effective
2026-04-15
Exact text from the filing
In order to complete the Redomiciliation, the boards of directors of each of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation (“ Wave-Delaware ”), approved the entry by Wave-Singapore and Wave-Delaware, respectively, into an Implementation Agreement (the “ Implementation Agreement ”). The Implementation Agreement was executed by Wave-Singapore and Wave-Delaware on April 15, 2026 and provides for a statutory procedure known as a scheme of arrangement (the “ Scheme of Arrangement ”) to be implemented by Wave-Singapore and Wave-Delaware under Singapore law, subject to approval of the shareholders of Wave-Singapore and the High Court of the Republic of Singapore.
View on SEC.gov

Browse all material agreements →

Wave Life Sciences Ltd. filing history →

Source: SEC EDGAR
accession 0001193125-26-157003
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.